Pharmaceutical pricing and market access is the crucial challenge for successful product launch toda...
Read moreThe objective of this research was to understand the processes and outputs from different European p...
Read moreSetting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...
Read moreSince 29 July 2016 NICE) has employed a new fast-track appraisal process for oncology drugs.
Read moreBiosimilars are becoming more widely available across Europe, with many payers at each level involve...
Read moreThe aim of this study is to compare the key aspects companies must consider when seeking HTA scienti...
Read moreThis research highlights the variability regarding the scientific advice submission processes and sc...
Read moreThe new NICE oncology appraisal process aims to enable fast-track appraisals, allowing earlier acces...
Read moreHow the pharmaceutical industry is investing in market access training capabilities to address today...
Read moreSince 29th July 2016 the NICE appraisal process for oncology indications in England has been modifie...
Read more